| 產(chǎn)品名稱 | Rapamycin - Sirolimus |
| 產(chǎn)品貨號 | Axon 2069 CAS [53123-88-9] MF C51H79NO13MW 914.17 Purity: 98% Soluble in DMSO Description Specific inhibitor of mTOR (mammalian target of Rapamycin); it binds the cytosolic protein FKBP12 and inhibits mTOR pathway by directly binding the mTORC1. Rapamycin selectively inhibits interleukin-2 (IL-2) activation of p70 S6 kinase. It prevents activation of T cells and B cells by inhibiting their response to IL-2. An immunosuppressant drug used to prevent rejection in organ transplantation, especially useful in kidney transplants; also used as a coronary stent coating References Certificates Categories Extra info CJ Kuo et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992, 358(6381), 70-73.? ? EJ Brown et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 1994, 369(6483) 756-758.? ? S Kobayashi et al. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci. 2007, 98(5), 726-33.? Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Immunology Immunomodulator mTOR PI3K-Akt-mTOR EC 2.7.11.1 Pfizer Licensed Products Specific inhibitor of mTOR; binds to FKBP12 Chemical name (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-ep Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [53123-88-9] Order Size Unit Price Stock 2 mg €85.00 In Stock |
| 產(chǎn)品價格 | 現(xiàn)貨詢價，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
Rapamycin - SirolimusAxon 2069 CAS [53123-88-9] MF C51H79NO13
Description
Specific inhibitor of mTOR (mammalian target of Rapamycin); it binds the cytosolic protein FKBP12 and inhibits mTOR pathway by directly binding the mTORC1. Rapamycin selectively inhibits interleukin-2 (IL-2) activation of p70 S6 kinase. It prevents activation of T cells and B cells by inhibiting their response to IL-2. An immunosuppressant drug used to prevent rejection in organ transplantation, especially useful in kidney transplants; also used as a coronary stent coating
Specific inhibitor of mTOR; binds to FKBP12
Chemical name(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-ep Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[53123-88-9] |
| 產(chǎn)品資料 |
